Among hospital-acquired infections, MRSA gets most of the attention, says a Purdue University researcher; this leaves the second most common hospital-acquired infection lurking in the shadows. Vancomycin-resistant enterococci (VRE), similar to MRSA, is characterized by its antibiotic resistance, making it especially dangerous and difficult to treat. However, Purdue College of Veterinary Medicine Microbiology Professor Dr. Mohamed Seleem aims to pull VRE from the shadows and battle the disease with increased speed.
Determined to swiftly find a new treatment for VRE, Seleem is taking a somewhat unique approach, using existing, repurposed drugs, rather than relying on antibiotics.
Read more at Inside Indiana Business.